NCT01689051View on ClinicalTrials.gov

Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Type 2 DiabetesBlod PressureGlucagon-like Peptide-1Human PhysiologyBlood Flow
Interventions
OTHER

human glucagon-like peptide 1 (7-36)amide

OTHER

human glucagon-like peptide 1 (9-36)amide

Trial Locations (1)

2900

Gentofte Hospital, Department of Cardiology, Hellerup

Sponsors

Collaborators (1)

Danish Heart Foundation
All Listed Sponsors
collaborator

Danish Heart Foundation

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER